Ipriflavone reverses the adverse effects of a low-calcium diet on the histology of the tibia in caged layers.
Lv WT, Yang YH, Ma LQ, Wang P, Li K.
Br Poult Sci · research support, non-u.s. gov't; journal article · DOI 10.1080/00071668.2013.878785 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för ipriflavone. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
15 träffarAntimutagenic activity of ipriflavone against the DNA-damage induced by cyclophosphamide in mice.
Delarmelina JM, Dutra JC, Batitucci Mdo C.
Food Chem Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.fct.2013.12.028The neuroprotective effects of ipriflavone against H ₂O ₂ and amyloid beta induced toxicity in human neuroblastoma SH-SY5Y cells.
Xiao Z, Huang C, Wu J, Sun L, Hao W, Leung LK, Huang J.
Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2013.09.023Inhibitory effects of isoflavonoids on rat prostate testosterone 5α-reductase.
Bae M, Woo M, Kusuma IW, Arung ET, Yang CH, Kim YU.
J Acupunct Meridian Stud · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jams.2012.07.022Determination of ipriflavone in human plasma by LC-MS and its application in a pharmacokinetic study.
Yun C, Ding L, Leng Y, Zhu H, Wen A, Yang L.
Biomed Chromatogr · journal article · DOI 10.1002/bmc.1641Effects of ipriflavone on caged layer bone metabolism in vitro and in vivo.
Yao J, Zhang J, Hou JF.
Poult Sci · controlled clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1093/ps/86.3.503Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY, Ipriflavone Multicenter European Fracture Study.
JAMA · clinical trial; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1001/jama.285.11.1482Ipriflavone: an important bone-building isoflavone.
Head KA.
Altern Med Rev · review; journal articleIpriflavone as an inhibitor of human cytochrome P450 enzymes.
Monostory K, Vereczkey L, Lévai F, Szatmári I.
Br J Pharmacol · clinical trial; research-article; journal article · DOI 10.1038/sj.bjp.0701633Ipriflavone: background.
Gennari C.
Calcif Tissue Int · review; journal article · DOI 10.1007/s002239900375In vitro and in vivo effects of ipriflavone on bone formation and bone biomechanics.
Civitelli R.
Calcif Tissue Int · review; journal article · DOI 10.1007/s002239900378The future of ipriflavone in the management of osteoporotic syndromes.
Avioli LV.
Calcif Tissue Int · review; journal article · DOI 10.1007/s002239900383Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis.
Reginster JY.
Bone Miner · review; journal article · DOI 10.1016/s0169-6009(08)80099-2Ipriflavone influences the osteoblastic phenotype in vitro.
Brandi ML.
Osteoporos Int · review; journal article · DOI 10.1007/bf01621914Experimental studies on the cardiological effects of ipriflavone on the isolated rabbit heart and in rat and dog.
Feuer L, Baráth P, Strauss I, Kékes E.
Arzneimittelforschung · journal article